Kimberly Finn is Vice President, Global Patient Centric Services for Marken. She has extensive experience in the clinical trials industry with over 25 years in roles within clinical operations and global project management in both pharma and CRO organizations. Kim’s expertise in protocol design and clinical strategy has contributed to successful on-time delivery of complex portfolios and she has directly contributed to the development of many New Drug Application (NDA) approved and marketed compounds.